PLOD2 and cancer: As shown in Figure 1, analysis of PLOD1, PLOD2, and PLOD3 mRNA expression in 20 cancer types (Oncomine dataset) showed significant upregulation and downregulation of the three PLOD isoforms in a number of cancers, including kidney cancer, compared with the corresponding normal tissues.